Morphocell

Engineering Hope for Adults and Children with Liver Disease

Montreal, United States · Founded 2018 · $50.0M raised

Headquarters
Montreal
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$50.0M
Last Round
$10.0M Extension RoundDec 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Morphocell Technologies is a Montreal-based regenerative medicine company developing the world's first effective cell-based treatments for severe liver diseases in adults and children. The company's lead product, ReLiver, uses iPSC-derived, tissue-engineered liver constructs to replace or supplement failing liver function without the need for invasive surgery or donor organ transplants. Morphocell completed a US$50 million Series A financing round in late 2025 and is advancing its platform through preclinical and clinical development. The company was co-founded by pediatric transplant hepatologist Dr. Massimiliano Paganelli.

Summary

Morphocell is a Biotech company based in Montreal, United States, founded in 2018. It has raised $50.0M in total across 2 rounds, most recently a $10.0M Extension Round in Dec 2025. Investors include Investissement Québec and CDP Venture Capital SGR.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundSeries A Add-onDec 2025
$10.0M

Sign up to see all 2 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Morphocell on Indexed.vc
<a href="https://indexed.vc/companies/morphocell"><img src="https://indexed.vc/api/badge/company/morphocell" alt="Morphocell on Indexed.vc" width="260" height="76" /></a>